These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33867830)

  • 1. The role of Fibrinogen-like proteins in Cancer.
    Yu J; Li J; Shen J; Du F; Wu X; Li M; Chen Y; Cho CH; Li X; Xiao Z; Zhao Y
    Int J Biol Sci; 2021; 17(4):1079-1087. PubMed ID: 33867830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGL1 and FGL2: emerging regulators of liver health and disease.
    Chen J; Wu L; Li Y
    Biomark Res; 2024 May; 12(1):53. PubMed ID: 38816776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two fibrinogen-like proteins, FGL1 and FGL2 are disulfide-linked subunits of oligomers that specifically bind nonviable spermatozoa.
    Nagdas SK; Winfrey VP; Olson GE
    Int J Biochem Cell Biol; 2016 Nov; 80():163-172. PubMed ID: 27732889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential.
    Liu XH; Qi LW; Alolga RN; Liu Q
    Int J Biol Sci; 2022; 18(1):292-300. PubMed ID: 34975333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer.
    Shi AP; Tang XY; Xiong YL; Zheng KF; Liu YJ; Shi XG; Lv Y; Jiang T; Ma N; Zhao JB
    Front Immunol; 2021; 12():785091. PubMed ID: 35111155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung Cancer.
    Zhu Y; Zhang L; Zha H; Yang F; Hu C; Chen L; Guo B; Zhu B
    Int J Biol Sci; 2017; 13(6):804-814. PubMed ID: 28656005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen-like protein 2: Its biological function across cell types and the potential to serve as an immunotherapy target for brain tumors.
    Zhang S; Rao G; Heimberger A; Li S
    Cytokine Growth Factor Rev; 2023 Feb; 69():73-79. PubMed ID: 36085259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer.
    Li JJ; Wang JH; Tian T; Liu J; Zheng YQ; Mo HY; Sheng H; Chen YX; Wu QN; Han Y; Liao K; Pan YQ; Zeng ZL; Liu ZX; Yang W; Xu RH; Ju HQ
    Nat Commun; 2023 Oct; 14(1):6690. PubMed ID: 37872170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development.
    Nayeb-Hashemi H; Desai A; Demchev V; Bronson RT; Hornick JL; Cohen DE; Ukomadu C
    Biochem Biophys Res Commun; 2015 Sep; 465(2):167-73. PubMed ID: 26225745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen-related protein, FGL2, of hamster cauda epididymal fluid: Purification, kinetic analysis of its prothrombinase activity, and its role in segregation of nonviable spermatozoa.
    Nagdas SK; Wallace S; Eaford D; Baker R; Carr K; Raychoudhuri SS
    Mol Reprod Dev; 2020 Dec; 87(12):1206-1218. PubMed ID: 33216420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
    Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment.
    Yang L; Li A; Lei Q; Zhang Y
    J Hematol Oncol; 2019 Nov; 12(1):125. PubMed ID: 31775797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells.
    Son Y; Shin NR; Kim SH; Park SC; Lee HJ
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting novel inhibitory receptors in cancer immunotherapy.
    Ding QQ; Chauvin JM; Zarour HM
    Semin Immunol; 2020 Jun; 49():101436. PubMed ID: 33288379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen-like protein 2 in inflammatory diseases: A future therapeutic target.
    Fu L; Liu Z; Liu Y
    Int Immunopharmacol; 2023 Mar; 116():109799. PubMed ID: 36764282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy.
    Qiu H; Shao Z; Wen X; Jiang J; Ma Q; Wang Y; Huang L; Ding X; Zhang L
    Front Immunol; 2021; 12():716710. PubMed ID: 34539652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.
    Xing Y; Ruan G; Ni H; Qin H; Chen S; Gu X; Shang J; Zhou Y; Tao X; Zheng L
    Front Immunol; 2021; 12():624725. PubMed ID: 34084160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of macrophages in anti-tumor immune responses: pathological significance and potential as therapeutic targets.
    Tsukamoto H; Komohara Y; Oshiumi H
    Hum Cell; 2021 Jul; 34(4):1031-1039. PubMed ID: 33905102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FGL2 prothrombinase contributes to the pathological process of experimental pulmonary hypertension.
    Fan C; Wang J; Mao C; Li W; Liu K; Wang Z
    J Appl Physiol (1985); 2019 Dec; 127(6):1677-1687. PubMed ID: 31580221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression.
    Yu H; Liu Y; Wang H; Wan X; Huang J; Yan W; Xi D; Luo X; Shen G; Ning Q
    Front Immunol; 2018; 9():2935. PubMed ID: 30619295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.